Novel prostate cancer treatment awarded US grant
This article was originally published in Clinica
Executive Summary
Research into a new way of selectively delivering anti-cancer drugs into prostate tumours without damage to normal surrounding tissues is being supported by a US grant worth just over $0.5m.